Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole study in cystic fibrosis patients with chronic Aspergillus infection
NL-OMON28850Active, not recruiting
- Sponsor
- Erasmus MC Sophia Children's Hospital
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of voriconazole in aspergillosis, sponsored by Erasmus MC Sophia Children's Hospital. Primary endpoint: Primary efficacy endpoint. Started Mar 2005; status: active, not recruiting.
02
Drugs
voriconazole
03
Conditions
aspergillosis
Beyond the preview
Go deeper on NL-OMON28850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28850.